我国生物医学工程技术和产业发展的扶持政策研究

Fostering Policies for Bio-medical Engineering and Its Industrial Growth in China

生物医学工程(BME)是当代最受重视、最具吸引力的高科技领域之一。我国的BME技术及产业与世界先进水平相比尚存在着很大差距,国内市场处于被西方发达国家垄断、瓜分的状态,产品贸易逆差巨大。在发达国家跨国公司的强力冲击下,我国BME产业在21世纪初面临着严重的生存危机。当前,国内在技术标准、贷款担保、进口税收等方面的滞后政策,很大程度上制约了我国BME产业的发展进程。因此,迫切需要比照发达国家经验,找出国内相关政策存在的缺陷,有针对性地提出扶持政策,以便抓住机遇,实现我国BME产业的跨越式发展。

： BME（bio-medical engineering） is nowadays a promising and very important high-tech industry, but in China the R＆D level of BME lagged far behind the world advanced level. In this respect, China＇s market has been monopolized by the western developed countries and the deficits in the trade of BME products is huge. The fact implies that China＇s BME industry is facing a survival crisis under such an impact in the early 21st century. The current situation is mainly because of out-of-date policies including technical standard, credit guarantee and import duty, which are restricting the sound growth of BME industry. It is urgently necessary to explore our policy flaws in comparison to the experience in developed countries so as to formulate appropriate fostering policies to achieve the goal of BME to grow by leaps and bounds.